Resonic — Finite-Lived Intangible Assets, Net
Products & Services · Finite-Lived Intangible Assets, NetAnalysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ3 2025
Last reportedQ3 2025
How to read this metric
A decreasing balance typically indicates ongoing amortization of the assets, while a sudden decrease may signal an impairment charge due to reduced commercial expectations. An increase suggests new capital investment or acquisitions related to the product line.
Detailed definition
This metric represents the carrying value of identifiable intangible assets associated with the Resonic product line, ne...
Peer comparison
Comparable to 'Net Intangible Assets' or 'Acquired Developed Technology' reported by other pharmaceutical or medical device companies for specific product segments.
Metric ID:
abbv_segment_resonic_finite_lived_intangible_assets_netHistorical Data
1 periods
| Q3 '25 | |
|---|---|
| Value | $407.00M |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's resonic — finite-lived intangible assets, net?
- AbbVie (ABBV) reported resonic — finite-lived intangible assets, net of $407.00M in Q3 2025.
- What does resonic — finite-lived intangible assets, net mean?
- The current book value of the Resonic product line's acquired technology and intellectual property after accounting for wear and tear or obsolescence.